Notes - Segment Information, Etc.

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7328181

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
809,000,000 JPY
75,579,000,000 JPY
63,348,000,000 JPY
3,022,000,000 JPY
8,399,000,000 JPY
8,285,000,000 JPY
621,000,000 JPY
67,493,000,000 JPY
2,343,000,000 JPY
56,243,000,000 JPY
Transactions with other segments
173,000,000 JPY
4,179,000,000 JPY
JPY
1,893,000,000 JPY
2,112,000,000 JPY
2,057,000,000 JPY
202,000,000 JPY
3,192,000,000 JPY
932,000,000 JPY
JPY
Other items
Depreciation
21,000,000 JPY
4,404,000,000 JPY
3,905,000,000 JPY
23,000,000 JPY
454,000,000 JPY
468,000,000 JPY
22,000,000 JPY
4,259,000,000 JPY
23,000,000 JPY
3,745,000,000 JPY
Increase in property, plant and equipment and intangible assets
150,000,000 JPY
4,090,000,000 JPY
3,187,000,000 JPY
39,000,000 JPY
712,000,000 JPY
1,617,000,000 JPY
3,000,000 JPY
7,467,000,000 JPY
18,000,000 JPY
5,828,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.